Alcon introduces NGENUITY® 3D Visualization System with DATAFUSION™ to simplify and customize vitreoretinal surgery in Europe
Sep 20, 2018
DATAFUSION software enables NGENUITY 3D Visualization System to integrate the CONSTELLATION® Vision System to streamline surgical data on one screen
New features represent Alcon’s commitment to advancing surgical visualization technology
NGENUITY 3D Visualization System with DATAFUSION presented at the 2018 Annual Meeting of European Society of Retina Specialists (EURETINA)
Vienna, September 20, 2018 – Alcon, the global leader in eye care and a division of Novartis, launches the new NGENUITY 3D Visualization System with DATAFUSION at the 36th Annual Meeting of European Society of Retina Specialists (EURETINA) in Vienna, Austria, September 21-22. The high-definition screen of the NGENUITY system will continue to provide retinal surgeons unprecedented 3D visualization of the back of the eye with greater depth and detail during surgery than traditional microscopes.1 With the addition of the DATAFUSION software, NGENUITY now also offers integration with the CONSTELLATION Vision System, the leading technology platform for vitreoretinal surgery.
“Alcon is bringing 3D visualization a step further by introducing the new DATAFUSION Software connecting NGENUITY 3D Visualization System with the CONSTELLATION Vision System. The union of these two advanced technologies offers a unique experience for surgeons to visualize on one single screen high quality 3D images as well as the key parameters to monitor patients during the surgery. This new feature adds an important benefit to the surgeon’s experience with NGENUITY,” said Stephan Eigenmann, Surgical Franchise Head, Alcon Europe, Middle East, Africa.
The DATAFUSION software integrates the CONSTELLATION Vision System and the NGENUITY 3D Visualization System, allowing surgeons to track key data parameters in real-time, such as intraocular pressure, flow rates, infusion pressure and laser power, on one screen. Additional functionality simplifies the surgical experience allowing for customization, including the introduction of four preset imaging modes, two footswitch control options, advanced 2D or 3D video capture, and graphic enhancement of the user interface and procedure flow to provide an improved white balance process.
The viewing platform of the NGENUITY 3D Visualization System revolutionized vitreoretinal surgery when it was first launched. Compared to traditional analog microscopes, NGENUITY delivers up to 48% percent increase in magnification to amplify the view for intricate tasks, up to 5 times better depth of field to maintain focus across an expanded surgical space, and up to 42% percent increase in depth resolution to resolve fine details when managing challenging pathologies.1
“The NGENUITY 3D Visualization System has changed my way of doing eye surgeries. With the addition of DATAFUSION, I can now see all the information I need from the Constellation Vision System right in front of me, especially the Intraocular Pressure and flow rate, at a glance, so that I can remain focused on the procedure itself”, said Carl Claes, Head of VR Department, St. Augustinus Hospital, Antwerp, Belgium.
The NGENUITY 3D Visualization System with DATAFUSION is now available and can be experienced first-hand, along with other new product offerings from Alcon, at the Alcon booth. A dedicated presentation will take place during Alcon’s symposium:
Fusing technologies into integrated solutions for every Vitreoretinal Surgery Saturday, September 22 -10.00-11.00 Reed Messe Hall C3 Moderator: Ramin Tadayoni (FR)
About Vitreoretinal Surgery
Vitreoretinal surgery is a sub-specialty of ophthalmology focused in diseases and surgery of the back of the eye including the retina and the vitreous body of the eye. The retina is a light-sensitive area that includes the macula, which is made-up of light-sensitive cells that provide sharp, detailed vision. The vitreous body of the eye is a clear gel that fills the space between the retina and the lens. The retina, the macula, and the vitreous body can all be subject to various diseases and conditions that can lead to blindness or vision loss and may require the attention of a vitreoretinal surgeon.
About NGENUITY 3D Visualization System
The NGENUITY 3D Visualization System was developed in collaboration with TrueVision® 3D Surgical, a California-based leader in digital 3D visualization and guidance for microsurgery. It consists of a 3D stereoscopic, high-definition digital video camera and workstation to provide magnified stereoscopic images of objects during micro-surgery. Additional functionality updates simplify the surgical experience allowing for customization, including the introduction of four preset imaging modes, two footswitch control options, advanced 2D or 3D video capture, and enhancement of the graphical user interface and procedure flow to provide an improved white balance process. Please refer to the User Manual for a complete list of appropriate uses, warnings and precautions.
Alcon is the global leader in eye care. As a division of Novartis, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our products touch the lives of more than 260 million people each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors, and there are millions more who are waiting for solutions to meet their eye care needs. Our purpose is reimagining eye care, and we do this through innovative products, partnerships with eye care professionals and programs that enhance access to quality eye care. Learn more at www.alcon.com.
Alcon Data on File. Yin L, Sarangapani R. Assessment of visual attributes for NGENUITY® 3D Visualization System 1.0 for digitally assisted vitreoretinal surgery. Alcon Modeling and Simulation. December 2017.